SCHEDULE: SEC Filing: C/M Capital and Affiliates Report 0% Stake in Catheter Precision

Multiple C/M Capital entities and associated individuals have filed a Schedule 13G, reporting 0% beneficial ownership of Catheter Precision, Inc. common stock as of March 31, 2026.

Summary

• This filing is an amendment to a Schedule 13G, which is used by beneficial owners of more than 5% of a class of a company's registered equity securities.
• The reporting persons include C/M Capital Master Fund, LP; WVP Emerging Manager Onshore Fund LLC; C/M Capital Partners, LP; Mercer Street Global Opportunity Fund, LLC; Mercer Street Capital Partners, LLC; Thomas Walsh; and Jonathan Juchno.
• As of March 31, 2026, all reporting persons collectively hold 0% of the outstanding common stock of Catheter Precision, Inc.
• The filing indicates that the shares of common stock were held by the Funds (C/M Master Fund, WVP Fund, and Mercer Fund).
• C/M Capital Partners, LP manages C/M Master Fund and WVP Fund, while Mercer Street Capital Partners, LLC manages Mercer Fund.
• Thomas Walsh and Jonathan Juchno are managing members of the general partner of C/M Capital Partners, and Mr. Juchno controls Mercer Capital Partners.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a neutral filing, primarily a procedural disclosure of zero beneficial ownership, offering no new financial or strategic information about Catheter Precision, Inc.

Future Outlook

No forward-looking statements or guidance were provided in this filing.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are routine disclosures for significant shareholders and do not inherently indicate a change in strategy or financial performance of the underlying company. The absence of reported ownership suggests these entities are not currently significant beneficial owners of Catheter Precision, Inc.

Key Dates

Keywords

Schedule 13G, SEC Filing, Beneficial Ownership, Catheter Precision, C/M Capital, Mercer Street Capital, Ownership Report